The White House today released a preliminary planning guide to inform jurisdictional, federal partner and pharmacy planning to distribute the Pfizer COVID-19 vaccine for children aged 6 months through 4 should the Food and Drug Administration authorize the vaccine for emergency use in this age group. According to the guide, pharmacies may have limited ability to vaccinate these younger children, so encouraging Vaccines for Children providers to enroll as COVID-19 vaccine providers will be critical to ensuring access to the vaccine. States will determine what locations receive the vaccine, as they have for previously authorized groups. The federal government and manufacturer plan to provide additional training to prepare participating providers and locations. The administration expects to update the guide as more information or COVID-19 vaccines for this age group become available. 
 

Headline
The Department of Health of Human Services Aug. 21 issued a request for information seeking feedback on immunization categories within the Aug. 10 executive…
Headline
For the 2025-2026 school year, exemptions from one or more vaccines among U.S. kindergartners was at 4.2%, increasing from 3.6% for the previous school year,…
Headline
The Department of Health and Human Services June 30 announced it will terminate emergency use authorization declarations for certain drugs and medical devices…
Headline
The Centers for Disease Control and Prevention Feb. 19 released a report on the low use of COVID-19 antiviral drugs among individuals age 65 and older, a…
Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…